Skip to Content

14 Results Found

  • Review
  • Open Access
11 Citations
3,922 Views
10 Pages

Emerging Role of [18F]FLT PET/CT in Lymphoid Malignancies: A Review of Clinical Results

  • Anna Giulia Nappi,
  • Giulia Santo,
  • Lorenzo Jonghi-Lavarini,
  • Alberto Miceli and ,
  • Achille Lazzarato,
  • Flavia La Torre,
  • Francesco Dondi and
  • Joana Gorica
  • + 3 authors+ 0 author

11 January 2024

Fluorine-18 fluorodeoxyglucose ([18F]FDG) is nowadays the leading positron emission tomography (PET) tracer for routine clinical work-ups in hematological malignancies; however, it is limited by false positive findings. Notably, false positives can o...

  • Article
  • Open Access
4 Citations
3,588 Views
16 Pages

Impact of [18F]FDG-PET and [18F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer

  • Tine N. Christensen,
  • Seppo W. Langer,
  • Gitte Persson,
  • Klaus Richter Larsen and ,
  • Annemarie G. Amtoft,
  • Sune H. Keller,
  • Andreas Kjaer and
  • Barbara Malene Fischer
  • + 3 authors+ 0 author

11 February 2021

Radiation-induced changes may cause a non-malignant high 2-deoxy-2-[18F]fluoro-d-glucose (FDG)-uptake. The 3′-deoxy-3′-[18F]fluorothymidine (FLT)-PET/CT performs better in the differential diagnosis of inflammatory changes and lung lesions with a hig...

(This article belongs to the Section Medical Imaging and Theranostics)
  • Article
  • Open Access
18 Citations
5,110 Views
7 Pages

Although 2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) is a sensitive nuclear medicine modality, specificity for characterizing lung cancer is limited. Tumor proliferation and early response to mol...

(This article belongs to the Section Medical Imaging and Theranostics)
  • Article
  • Open Access
8 Citations
5,113 Views
10 Pages

Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine (18F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study

  • Kalevi Kairemo,
  • Elmer B. Santos,
  • Homer A. Macapinlac,
  • Shreyaskumar Patel and ,
  • Anthony P. Conley,
  • David S. Hong and
  • Vivek Subbiah
  • + 2 authors+ 0 author

25 February 2020

Although 3′-deoxy-3′[(18)F]-fluorothymidine (FLT)-positron emission tomography (PET) has been utilized for tumor response assessment to neoadjuvant chemotherapy in soft tissue sarcomas, it has not been exploited for the assessment of earl...

(This article belongs to the Section Medical Imaging and Theranostics)
  • Article
  • Open Access
13 Citations
6,264 Views
10 Pages

Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions

  • Alexandra Nikaki,
  • Vassilios Papadopoulos,
  • Varvara Valotassiou,
  • Roxani Efthymiadou and ,
  • George Angelidis,
  • Ioannis Tsougos,
  • Vassilios Prassopoulos and
  • Panagiotis Georgoulias
  • + 3 authors+ 0 author

18F-fluorothymidine (18F-FLT) is a radiolabeled thymidine analog that has been reported to help monitor tumor proliferation and has been studied in primary brain tumors; however, knowledge about 18F-FLT positron emission tomography/computed tomograph...

(This article belongs to the Special Issue Brain Imaging)
  • Brief Report
  • Open Access
8 Citations
6,893 Views
9 Pages

Fluorothymidine is a thymidine analog labeled with fluorine-18 fluorothymidine for positron emission tomography (18F-FLT-PET) imaging. Thymidine is a nucleic acid that is used to build DNA. Fluorine-18 fluorothymidine (18F-FLT) utilizes the same meta...

(This article belongs to the Special Issue Imaging of Early Response in Cancer Management)
  • Article
  • Open Access
2 Citations
2,526 Views
10 Pages

Differences between [18F]FLT and [18F]FDG Uptake in PET/CT Imaging in CC Depend on Vaginal Bacteriology

  • Ewa Burchardt,
  • Zaneta Warenczak-Florczak,
  • Paulina Cegła,
  • Adam Piotrowski and ,
  • Zefiryn Cybulski,
  • Wojciech Burchardt,
  • Andrzej Roszak and
  • Witold Cholewiński
  • + 3 authors+ 0 author

This study aims to investigate if vaginal bacteriology obtained prior to treatment influences the 3′-deoxy-3 18F-fluorothymidine (FLT) [18F]FLT and 2-deoxy-2-[18F]fluoro-d-glucose (2-[18F]FDG) [18F]FDG parameters in positron emission tomography...

(This article belongs to the Special Issue Imaging of Gynecological Disease)
  • Article
  • Open Access
8 Citations
4,579 Views
14 Pages

Comparison of 18F-fluorothymidine Positron Emission Tomography/Computed Tomography and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer

  • Mio Mori,
  • Tomoyuki Fujioka,
  • Ryota Ichikawa,
  • Reina Inomata and ,
  • Leona Katsuta,
  • Yuka Yashima,
  • Emi Yamaga,
  • Junichi Tsuchiya,
  • Kumiko Hayashi and
  • Ukihide Tateishi
  • + 10 authors+ 5 authors

11 October 2022

The uptake of 18F-fluorothymidine (18F-FLT) depends on cells’ proliferative rates. We compared the characteristics of 18F-FLT positron emission tomography/computed tomography (PET/CT) with those of 18F-fluorodeoxyglucose (18F-FDG) PET/CT for br...

  • Case Report
  • Open Access
3 Citations
8,327 Views
11 Pages

Use of Molecular Imaging Markers of Glycolysis, Hypoxia and Proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a Dog with Fibrosarcoma: The Importance of Individualized Treatment Planning and Monitoring

  • Kamilla Westarp Zornhagen,
  • Malene M. Clausen,
  • Anders E. Hansen,
  • Ian Law and ,
  • Fintan J. McEvoy,
  • Svend A. Engelholm,
  • Andreas Kjær and
  • Annemarie T. Kristensen
  • + 3 authors+ 0 author

11 September 2015

Glycolysis, hypoxia, and proliferation are important factors in the tumor microenvironment contributing to treatment-resistant aggressiveness. Imaging these factors using combined functional positron emission tomography and computed tomography can po...

(This article belongs to the Collection Feature Papers)
  • Article
  • Open Access
1 Citations
1,920 Views
9 Pages

31 May 2024

Background/Objectives: The inhibitory effects of tyrosine kinase inhibitors (TKIs) on glucose uptake through their binding to human glucose transporter-1 (GLUT-1) have been well documented. Thus, our research aimed to explore the potential impact of...

(This article belongs to the Section Nuclear Medicine & Radiology)
  • Brief Report
  • Open Access
1 Citations
3,098 Views
5 Pages

[18F]Fluorothymidine Uptake in the Porcine Pancreatic Elastase-Induced Model of Abdominal Aortic Aneurysm

  • Richa Gandhi,
  • Joanna Koch-Paszkowski,
  • Charalampos Tsoumpas and
  • Marc A. Bailey

The porcine pancreatic elastase (PPE) model is a common preclinical model of abdominal aortic aneurysms (AAA). Some notable characteristics of this model include the low aortic rupture rate, non-progressive disease course, and infra-renal AAA formati...

(This article belongs to the Section Medical Imaging)
  • Case Report
  • Open Access
2,711 Views
12 Pages

30 November 2023

Psammocarcinoma (PsC) represents a rare form of low-grade serous tumor of the ovary or peritoneum. Although ovarian cancer generally has a poor prognosis in its late stages, PsC seems to have a more indolent course. We present a patient with a histor...

(This article belongs to the Section Gynecologic Oncology)
  • Review
  • Open Access
90 Citations
7,705 Views
16 Pages

Diagnostic Performance and Prognostic Value of PET/CT with Different Tracers for Brain Tumors: A Systematic Review of Published Meta-Analyses

  • Giorgio Treglia,
  • Barbara Muoio,
  • Gianluca Trevisi,
  • Maria Vittoria Mattoli and ,
  • Domenico Albano,
  • Francesco Bertagna and
  • Luca Giovanella
  • + 2 authors+ 0 author

20 September 2019

Background: Several meta-analyses reporting data on the diagnostic performance or prognostic value of positron emission tomography (PET) with different tracers in detecting brain tumors have been published so far. This review article was written to s...

(This article belongs to the Special Issue Cancer Molecular Imaging)
  • Article
  • Open Access
5 Citations
2,927 Views
15 Pages

Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models

  • Paolo Rainone,
  • Silvia Valtorta,
  • Chiara Villa,
  • Sergio Todde and ,
  • Massimiliano Cadamuro,
  • Gloria Bertoli,
  • Donatella Conconi,
  • Marialuisa Lavitrano and
  • Rosa Maria Moresco
  • + 4 authors+ 0 author

15 September 2023

Breast cancer (BC) is the most frequent cancer and the second leading cause of death in women. A typical feature of BC cells is the metabolic shift toward increased glycolysis, which has become an interesting therapeutic target for metabolic drugs su...

(This article belongs to the Special Issue Molecular Basis and Advances of Targeted Therapy for Breast Cancer)